AST and ALT levels were significantly higher in the HCC group than in the non-HCC group (69 ± 41 and 67 ± 43 IU/L vs. 49 ± 34 and 55 ± 49 IU/L, respectively). The gene discussed is GPT; the disease is hepatocellular carcinoma.